Lv1
10 积分 2024-10-15 加入
Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat
4天前
已完结
FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid
4天前
已完结
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial
4天前
已完结
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis
4天前
已完结
Identifying the Optimal Treatment for Patients with Hepatocellular Carcinoma and Clinically Significant Portal Hypertension: A Multicenter Propensity Score-Weighted Analysis
6天前
已完结
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study
21天前
已完结
Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study
21天前
已完结
Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat
21天前
已完结
Review Article: Ileal Bile Acid Transport ( IBAT ) Inhibitors as an Emerging Treatment for Cholestatic Liver Disease
22天前
已关闭
What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches
24天前
已完结
皖公网安备34019202002308
